ArticleCureus2026
Beyond Negative Electrophoresis and Immunofixation: A Three-Case Series of Non-secretory Multiple Myeloma.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-secretory multiple myeloma is an uncommon plasma cell neoplasm in which serum and urine electrophoresis and immunofixation fail to identify a measurable monoclonal component. This phenotype may delay diagnosis and make conventional biochemical monitoring difficult. We report three cases of clinically non-secretory multiple myeloma presenting with anemia and multifocal skeletal involvement despite negative monoclonal protein studies. Case 1 was a 33-year-old man with progressive fatigue, normocytic anemia, normal renal function and calcium levels, negative serum and urine monoclonal studies, and a normal serum free light chain ratio. Bone marrow aspiration showed 19% plasma cells, whereas bone marrow biopsy demonstrated extensive CD138-positive plasma cell infiltration; 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) revealed multifocal medullary lesions. Case 2 was a 63-year-old woman with low back pain and anemia, negative serum and urine immunofixation, and a normal serum free light chain ratio. Bone marrow aspiration showed 94% plasma cells, and 18F-FDG PET/CT demonstrated hypermetabolic skeletal lesions. She achieved partial remission after eight cycles of bortezomib, lenalidomide, and dexamethasone. Case 3 was a 68-year-old woman with fatigue, diffuse bone pain, anemia, negative serum and urine immunofixation, a normal serum free light chain ratio, 18% marrow plasma cells, and extensive PET/CT-positive skeletal disease. These cases emphasize that negative electrophoresis and immunofixation should not exclude multiple myeloma when the clinical, marrow, and imaging findings are suggestive. Bone marrow evaluation and whole-body imaging are central to diagnosis and follow-up in this rare entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.